Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05906888Completed

Weaning With Tracheostomy - an Observational Study on Patient-centered Outcomes

Role: collaborator

NCT06082492Not ApplicableRecruiting

The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients

Role: collaborator

NCT06350968Recruiting

Implementation of Online Advance Care Planning Tool for (Hemato-)Oncological Patients Within the Cancer Network Concord

Role: collaborator

NCT06066385Not ApplicableUnknown

Suture Techniques to Reduce the Incidence of Incisional Hernia: LTFU STITCH Trial

Role: collaborator

All 4 trials loaded